CRISPR/Cas9 plays a role in the IFN signaling pathway, ERK/MAPK signaling pathway, Wnt/β-catenin signaling pathway, PI3K/AKT signaling pathway and other mechanisms in chronic inflammation and tumor immune resistance. This evidence concerns the gene AKT1 and neoplasm.